Novartis AG (NOVNEE) - Financials, balance sheet (quarterly)

99.089996 CHF

0.49

0.50%

Last update Oct 31, 4:43 PM CET

Market closed

Day range

99.089996

98.67000

99.78000

Previous close

98.60000

Open

99.67000

Access this stock data via API

Novartis AG

99.09

0.49

0.50%

Financials

Balance sheet

Fiscal date	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Total assets	83.7B	80.2B	82.0B	83.0B
Current assets	20.8B	20.1B	23.8B	25.1B
Cash	—	—	2.1B	—
Cash equivalents	—	—	7.1B	—
Cash and cash equivalents	5.3B	5.7B	9.2B	10.9B
Other short term investments	275.9M	104.3M	1.5B	329.6M
Accounts receivable	7.3B	6.9B	6.0B	6.4B
Other receivables	—	—	1.2B	—
Inventory	5.1B	4.7B	4.6B	4.8B
Prepaid assets	—	—	790.0M	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	85.0M	—
Other current assets	2.8B	2.7B	—	2.5B
Non current assets	62.9B	60.0B	58.2B	58.0B
Properties	9.5B	8.9B	46.5M	9.0B
Land and improvements	—	—	680.1M	—
Machinery furniture equipment	—	—	7.4B	—
Construction in progress	—	—	1.3B	—
Leases	—	—	—	—
Accumulated depreciation	—	—	-8.9B	—
Goodwill	64.4B	62.1B	61.3B	62.4B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	23.4B	22.0B	21.6B	22.4B
Investments and advances	1.7B	1.7B	904.6M	1.8B
Other non current assets	7.8B	7.4B	4.9B	4.8B
Total liabilities	50.0B	49.3B	46.6B	48.2B
Current liabilities	25.4B	25.4B	23.0B	22.6B
Accounts payable	3.6B	3.4B	3.7B	3.3B
Accrued expenses	—	—	1.7B	—
Short term debt	6.9B	6.5B	6.7B	5.5B
Deferred revenue	—	—	101.9M	—
Tax payable	2.3B	2.1B	1.8B	1.7B
Pensions	—	—	2.0B	—
Other current liabilities	12.7B	13.4B	340.0M	12.1B
Non current liabilities	24.6B	24.0B	23.6B	25.6B
Long term provisions	—	—	449.9M	—
Long term debt	19.3B	18.6B	18.4B	20.3B
Provision for risks and charges	—	—	—	—
Deferred liabilities	1.9B	2.0B	1.9B	1.8B
Derivative product liabilities	—	—	—	—
Other non current liabilities	3.4B	3.3B	834.9M	3.5B
Shareholders equity
Common stock	614.3M	614.3M	636.0M	636.0M
Retained earnings	33.3B	32.0B	37.3B	37.1B
Other shareholders equity	-220.5M	-1.8B	-2.6B	-3.0B
Total shareholders equity	33.7B	30.8B	35.4B	34.8B
Additional paid in capital	—	—	—	—
Treasury stock	26.5M	15.2M	42.5M	32.1M
Minority interest	55.3M	66.6M	64.2M	99.4M